Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00913640 · ClinicalTrials.gov registry record
Prospective Memory in Parkinson's Disease
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 52
- Enrollment target
NCT00913640: Completed study, sponsored by Washington University School of Medicine.
NCT00913640 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 52 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00913640 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
Study Summary
The investigators tested whether prospective memory is impaired in individuals with Parkinson's Disease compared to controls using reliable and validated experimental measures. Also, the investigators assessed the impact of Parkinson's medication on prospective memory performance in PD to better estimate prospective memory function in PD patients' everyday (chronically treated) life.
Primary Outcome
Prospective Memory Task; Score range is 0-100%, with higher scores being better performance.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2009-11-18 |
| Est. Completion | 2010-08-27 |
What the finished NCT00913640 record still lists
NCT00913640 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 52 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00913640 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00913640 about?
NCT00913640 is a clinical study titled "Prospective Memory in Parkinson's Disease". The investigators tested whether prospective memory is impaired in individuals with Parkinson's Disease compared to controls using reliable and validated experimental measures. Also, the investigators assessed the impact of Parkinson's medication on prospective memory performance in PD to better est...
What is the current status of trial NCT00913640?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2009-11-18. Estimated completion is 2010-08-27.
Who is sponsoring clinical trial NCT00913640?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI